Cell Mar 18, 2026 Deep-learning-based <em>de novo</em> discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes
FierceBiotech Mar 12, 2026 Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
Endpoints News Mar 12, 2026 Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank
FierceBiotech Feb 25, 2026 Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess
BioPharma Dive Feb 24, 2026 Novo, searching for a spark, spotlights new data for three-pronged obesity drug
Endpoints News Feb 9, 2026 Novo Nordisk sues Hims over Wegovy patent infringement, considers seeking 'hundreds of millions' in damages